Influence

February 2025

• 2/28 - Predicting Alzheimer’s disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling

January 2025

• 1/22 - AGA Institute Quality Indicator Development for Irritable Bowel Syndrome

• 1/15 - Mental Health Utilization Among Transgender Veterans

• 1/14 - Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

• 1/10 - Asthma Among Children With Primary Ciliary Dyskinesia

December 2024

• 12/23 - Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age

• 12/17 - Regenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers

• 12/11 - Is the Multitarget Stool DNA Test Just a Better “FIT” for Colorectal Cancer Screening?

• 12/4 - Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States

• 12/1 - Optimal Transport-Based Transcriptomic Mapping Revealed Atypical Disease Progression Subtypes in Living Alzheimer’s Disease Patients

November 2024

• 11/19 - Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

• 11/18 - Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

• 11/13 - AMIA honors Regenstrief researcher with leadership award

• 11/11 - Regenstrief researchers share international conference stage

October 2024

• 10/29 - FDA approves Cologuard Plus™ test; Regenstrief researcher principal investigator for related study

• 10/25 - Regenstrief president participates in media panel with national experts

• 10/25 - Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

• 10/24 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement

• 10/22 - Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers

• 10/1 - Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers

• 10/1 - Regenstrief Institute researcher highlights qualitative outcomes from breast cancer study at international conference

September 2024

• 9/25 - Picking Up PrEP-Role of Clinician Specialty

• 9/18 - NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024

• 9/17 - Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement

• 9/12 - Experiences With Unionization Among General Surgery Resident Physicians, Faculty, and Staff

• 9/4 - Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

August 2024

• 8/16 - NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024

• 8/13 - Neighborhood Resources Associated With Psychological Trajectories and Neural Reactivity to Reward After Trauma

• 8/7 - Impact of interhospital transfer on patients with Alzheimer’s disease and other related dementias

July 2024

• 7/24 - Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years – VISION Network, United States, July 2022-June 2023

• 7/20 - Pregnancy and parenthood among US surgical residents

• 7/19 - Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone

• 7/18 - Efficacy of a Pain Self-Management Intervention Tailored to People With HIV: A Randomized Clinical Trial

• 7/17 - Experiences with unionization among general surgery resident physicians, faculty and staff

• 7/10 - Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?

June 2024

• 6/25 - Risk factors for dementia in older intensive care unit (ICU) survivors

• 6/5 - 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma

May 2024

• 5/29 - Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

• 5/14 - Study provides blueprint for hybrid-virtual home visit model to support patients who do not live close to a hospital

• 5/7 - Effect of modernized collaborative care for depression on depressive symptoms and cardiovascular disease risk biomarkers: eIMPACT randomized controlled trial

• 5/1 - Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial

April 2024

• 4/23 - Call for Papers on Artificial Intelligence Applied to Pediatric Care

• 4/2 - Primary Care Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement

March 2024

• 3/26 - An Integrative Review of the State of POLST Science: What Do We Know and Where Do We Go?

• 3/20 - HIV, Social Networks, and Loneliness among Older Adults in Uganda

• 3/14 - Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

• 3/5 - Institutional Variability in Respiratory Support use for Pediatric Critical Asthma: A Multicenter Retrospective Study 

• 3/1 - The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

February 2024

• 2/26 - Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical Trial 

September 2023

• 9/1 - Regenstrief researcher named chair of quality committee of one of nation’s largest medical professional organizations